Egnyte, the leading cloud provider of smart content collaboration and governance, is experiencing exponential growth in the most highly regulated healthcare and life sciences industries, including biotech, medical devices, pharmaceuticals, and more. Working with lab protocols, patient data, test results, and other Protected Health Information (PHI), thousands of organizations in these industries rely on Egnyte to create a secure digital workplace where content can be easily shared, managed, and protected.
“In the healthcare and life sciences industries, enabling secure collaboration and coupling that with proper protocols for data management and data protection are paramount,” said Kris Lahiri, Egnyte Co-Founder and Chief Information Security Officer. “These organizations are finding that the Egnyte platform gives them the flexibility to use the productivity tools they need without having to worry about non-compliance or potential breach, which is making us a rising star in these industries.”
The Egnyte platform provides collaboration and management solutions that go beyond simple file sync and share. Egnyte improves the way doctors, nurses, project managers, lab researchers, and patients access their content, while also ensuring organizations maintain complete visibility, control, and compliance.
“The Egnyte platform provides the kind of flexibility that companies need when they are scaling their digital environment, specifically in our industry, which requires a high level of visibility and control for compliance,” said John Keilty, Chief Data Sciences Officer at Decibel Therapeutics and Strategic Advisor at Third Rock Ventures. “Egnyte’s solutions have been instrumental in the growth of so many of the companies that we work with that we have made it a de–facto standard for a majority of our portfolio companies.”
A survey of Egnyte’s top customers in healthcare and life sciences showed that they chose the Egnyte platform for its ability to handle all of their collaboration and content management needs, including:
“Bio-Techne’s focus on continuous innovation and growth of our unique portfolio of Life Sciences products aligns perfectly with the capabilities of Egnyte Connect. Our rapid expansion, coupled with the need to quickly and securely share information with our global customers and staff is why Egnyte has become one of our most critical business tools,” said Aaron Froberg, Director of IT at Bio-Techne. “In addition to having the right technology, Egnyte has gone above and beyond as a service provider, transforming themselves into a valuable partner for us as we continue to grow our business.”
“A lot of the consumer-grade solutions on the market have a permission model that requires you to set individual permissions at every level of your infrastructure, which just doesn’t work for us as we grow our business and scale our operations,” said Jeffrey Reed, Director of IT at Voyager Therapeutics, “The Egnyte platform stands out because it enables us to migrate our active directory, set group policies at the folder level, and dig into granular permissions at the file level, which has made managing our employees easier than ever before.”
Egnyte delivers secure content collaboration, compliant data protection and simple infrastructure modernization; all through a single SaaS solution. Founded in 2007, Egnyte is privately held, headquartered in Mountain View, CA and supports thousands of businesses worldwide. Investors include Google Ventures, Kleiner Perkins, Caufield & Byers, CenturyLink and Seagate Technology.
VP, Corporate Communications